PlainRecalls
FDA Drug Low Class III Terminated

Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL), 10 mL single-use vials, Rx Only, Mfd. by Exela Pharma Sciences, LLC, Lenoir, NC, Dist. by: West-ward Pharmaceutical Corp., Eatontown, NJ --- NDC 0143-9689-10

Reported: July 17, 2013 Initiated: May 13, 2013 #D-691-2013

Product Description

Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL), 10 mL single-use vials, Rx Only, Mfd. by Exela Pharma Sciences, LLC, Lenoir, NC, Dist. by: West-ward Pharmaceutical Corp., Eatontown, NJ --- NDC 0143-9689-10

Reason for Recall

Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D)

Details

Units Affected
Lot PLNJ1201 -16,880 vials ; Lot PLNJ1202 - 16,960 vials
Distribution
Nationwide
Location
Eatontown, NJ

Frequently Asked Questions

What product was recalled?
Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL), 10 mL single-use vials, Rx Only, Mfd. by Exela Pharma Sciences, LLC, Lenoir, NC, Dist. by: West-ward Pharmaceutical Corp., Eatontown, NJ --- NDC 0143-9689-10. Recalled by West-ward Pharmaceutical Corp.. Units affected: Lot PLNJ1201 -16,880 vials ; Lot PLNJ1202 - 16,960 vials.
Why was this product recalled?
Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D)
Which agency issued this recall?
This recall was issued by the FDA Drug on July 17, 2013. Severity: Low. Recall number: D-691-2013.